Record🤔

uri:

"at://did:plc:jzllj7322hejjiu6hipptmef/app.bsky.feed.post/3juhrwogrmu2s"

cid:

"bafyreids7f25pc2gx7zuaa47aaton2gfbw3kr7ckdwbmos5gtpb32gzdmy"

value:

text:

"Read this week’s @bloombergnews.bsky.social Businessweek cover story by Emma Court and Robert Langreth:

Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About

https://www.bloomberg.com/news/features/2023-04-27/ozempic-s-high-cost-limits-access-to-weight-loss-drug"

$type:

"app.bsky.feed.post"

embed:

$type:

"app.bsky.embed.external"

external:

uri:

"https://www.bloomberg.com/news/features/2023-04-27/ozempic-s-high-cost-limits-access-to-weight-loss-drug"

thumb:

View blob content

$type:

"blob"

ref:

$link:

"bafkreigokprrua65ee7yzzcfkitwrgeqobtgd3xuzendxh3yyw6hqg7aqm"

mimeType:

"image/jpeg"

size:

298705

title:

"Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About"

description:

"Ozempic, Wegovy and Mounjaro can cause dramatic weight loss, and could create a market worth $150 billion a year."

facets:

• $type:

  "app.bsky.richtext.facet"

  index:

  byteEnd:

  45

  byteStart:

  19

  features:

  • did:

    "did:plc:uewxgchsjy4kmtu7dcxa77us"

    $type:

    "app.bsky.richtext.facet#mention"

• index:

  byteEnd:

  288

  byteStart:

  184

  features:

  • uri:

    "https://www.bloomberg.com/news/features/2023-04-27/ozempic-s-high-cost-limits-access-to-weight-loss-drug"

    $type:

    "app.bsky.richtext.facet#link"

createdAt:

"2023-04-28T23:38:43.964Z"